Clinical Implications of Canagliflozin Treatment in Patients With Type 2 Diabetes

IN BRIEF Sodium glucose cotransporter 2 (SGLT2) inhibitors are a new class of antihyperglycemic agents that lower blood glucose levels in patients with type 2 diabetes. SGLT2 inhibitors have an insulin-independent mechanism of action, acting to inhibit the reabsorption of glucose in the kidney, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Valentine, Virginia, Hinnen, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2015
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299744/
https://www.ncbi.nlm.nih.gov/pubmed/25653467
http://dx.doi.org/10.2337/diaclin.33.1.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299744/
https://www.ncbi.nlm.nih.gov/pubmed/25653467
http://dx.doi.org/10.2337/diaclin.33.1.5

Ejemplares similares